Episode Details
Back to Episodes
Pharmaceutical Executive Daily: TrumpRx's Critical Blind Spot
Published 5 months ago
Description
In today’s Pharmaceutical Executive Daily, new analysis highlights access gaps in the TrumpRx framework, the FDA awards a national priority voucher tied to Tecvayli in multiple myeloma, and Sobi announces a $1.5 billion agreement to acquire a gout therapy.